Trial Profile
A study to evaluate the regulatory T Cell and cytokine levels post-tocilizumab desensitization in HLA-sensitized patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Immunoglobulins
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- 27 Dec 2015 New trial record